Found 20 matching trials
Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC PHASE3 This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT PHASE4 Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma PHASE2 Cadonilimab is a first-in-class bispecific, humanized IgG1 antibody targeti...
Show More Location
Eastern hepatobilliary surgery hospital
Learn More & Join Trial
Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT NA This is a multicentri prospective cohort study to investigate the safety an...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC PHASE3 This trial is is an open label, multicenter, randomized controlled phase 3 ...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC) NA this multi-center prospective cohort study is to evaluate the efficacy and ...
Show More Location
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Learn More & Join Trial
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma PHASE2 This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Show More Location
Multiple Locations
Learn More & Join Trial
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma N/A The malignant degree of middle and advanced liver cancer is very high, and ...
Show More Location
The First Affiiated Hospital of Sun Yat-sen University
Learn More & Join Trial
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD) NA This is a pilot study with a single arm in a single center assessing safety...
Show More Location
Multiple Locations
Learn More & Join Trial
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma PHASE2 This is a phase 2 single-arm, open-label clinical trial determining efficac...
Show More Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Learn More & Join Trial